Comparative effectiveness of Propranolol versus Risperidone on core symptoms in children with Autism Spectrum Disorder - NI

Government Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•1. Diagnosis of autism spectrum disorder confirmed by DSM-5.
•2. Age range should be 4-12 years
•3. Any gender
•4. Caregivers willing to give consent and children (> 7 years old) willing to give assent.

•1. Children with co-morbid psychiatric illness except attention deficit hyperactivity disorder
•2. Children with Substance Use Disorders.
•3. Children with evidence of organic brain syndrome or moderate to severe intellectual
•disability.
•4. Children with any chronic medical conditions such as epilepsy, diabetes mellitus or on
•medications for the same.
•5. Children with current reactive airway disease, untreated thyroid disease, bradycardia,
•hypotension, unexplained syncope, current major depression, taking medications that
•interact with propranolol (e.g., alpha-2 agonists).
•6. Children on treatment with propranolol or risperidone in the past.
•7. Children with family history of Asthma.
•8. Children who are nonverbal from the start.

发起方

Government Medical College and Hospital